Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782117 · ClinicalTrials.gov registry record · NA
Luminopia One Pilot Study
A NA study, sponsored by Luminopia.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT02782117 is a NA study that has completed, run by Luminopia. The registered enrollment target is 84 participants.
The verdict
NCT02782117, a NA study, has completed, sponsored by Luminopia.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
A single-arm, multi-center, open-label pilot study to evaluate the feasibility, safety, and efficacy of the Luminopia One digital therapeutic in improving visual acuity in a pediatric amblyopia population.
Interventions
- DEVICE Luminopia One
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02782117
The ClinicalTrials.gov registry entry for NCT02782117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Luminopia, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Luminopia One is the first listed.
NCT02782117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02782117 about?
NCT02782117 is a clinical study titled "Luminopia One Pilot Study". A single-arm, multi-center, open-label pilot study to evaluate the feasibility, safety, and efficacy of the Luminopia One digital therapeutic in improving visual acuity in a pediatric amblyopia population.
What is the current status of trial NCT02782117?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2017-08-01. Estimated completion is 2019-02-06.
What interventions are being tested in trial NCT02782117?
The interventions under investigation include: Luminopia One (DEVICE).
Who is sponsoring clinical trial NCT02782117?
This trial is sponsored by Luminopia, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.